SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-244400
Filing Date
2011-09-09
Accepted
2011-09-09 14:25:24
Documents
12
Period of Report
2011-07-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d232194d10q.htm 10-Q 1231302
2 LEADERSHIP INCENTIVE PLAN d232194dex101.htm EX-10.1 146947
3 INCENTIVE STOCK OPTION PLAN d232194dex102.htm EX-10.2 92772
4 EMPLOYMENT AGREEMENT d232194dex103.htm EX-10.3 126826
5 SECTION 302 CEO CERTIFICATION d232194dex311.htm EX-31.1 6001
6 SECTION 302 CFO CERTIFICATION d232194dex312.htm EX-31.2 6004
7 SECTION 906 CEO CERTIFICATION d232194dex321.htm EX-32.1 5165
8 SECTION 906 CFO CERTIFICATION d232194dex322.htm EX-32.2 5165
9 GRAPHIC g232194g13e32.jpg GRAPHIC 4583
10 GRAPHIC g232194g25s23.jpg GRAPHIC 12567
11 GRAPHIC g232194g72g44.jpg GRAPHIC 2933
12 GRAPHIC g232194g72x58.jpg GRAPHIC 4276
  Complete submission text file 0001193125-11-244400.txt   1655362
Mailing Address 7070 MISSISSAUGA ROAD, SUITE 350 MISSISSAUGA ON A6 L5N7J8
Business Address C/O PATHEON PHARMACEUTICALS SERVICES INC 4721 EMPEROR BOULEVARD, SUITE 200 DURHAM NC 27703 905-821-4001
PATHEON INC (Filer) CIK: 0001400431 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1031
Type: 10-Q | Act: 34 | File No.: 000-54283 | Film No.: 111083176
SIC: 2834 Pharmaceutical Preparations